Public health officials offer scant details on U.S. coronavirus patients
How important is communication with the public during the beginning of an outbreak like the one we've seen associated with coronavirus?
"It's essential to have constant and good communication because one of the things you're doing is setting guiding and managing people's expectations. A lot of times we think that we're trying to give people information. We are but we're also trying to get them to kind of understand what's happening how it's unfolding how it could unfold so that they have the appropriate and best responses."
Does all the attention paid to coronavirus distract from potentially more important public health issues such as influenza?
"You know, one of the challenges when you have something like coronavirus which is new and is getting a lot of attention is are people going to pay attention to other more likely health threats? And I think CDC and other organizations are aware of that. And CDC is still trying to get messages out regarding influenza. I think one of the challenges that's mostly probably on the media front is that reporters who are following coronavirus they are focused almost exclusively on coronavirus. They just don't have the time and ability to cover more than one disease or health issue at a time."
What lessons have we learned from previous outbreaks ?
"There have been many lessons that have been learned. One of the first lessons is that you need to get information out quickly to more than one audience. And as a result, CDC and other organizations are not just working to get information out through the news media. They're working to get information out through multiple channels, such as their Web site such as health care providers, such as partners people who can reach other entities airlines traveler travelers cruise lines. So there are a lot of things that are happening that are not quite as visible as the media relations." Source:
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology